Correction of a pathogenic gene mutation in human embryos | Nature
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation | Nature Reviews Molecular Cell Biology
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
Nature-inspired CRISPR enzymes for expansive genome editing | MIT News | Massachusetts Institute of Technology
The CRISPR tool kit for genome editing and beyond | Nature Communications
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells | Nature Communications
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | Nature
What's new in clinical CRISPR? | Nature Medicine
New CRISPR-based tool inserts large DNA sequences at desired sites in cells | MIT News | Massachusetts Institute of Technology
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
A first step toward in vivo gene editing in patients | Nature Medicine
CRISPR-based diagnostics | Nature Biomedical Engineering
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
CRISPR-Cas immunity in prokaryotes | Nature
Structural biology of CRISPR–Cas immunity and genome editing enzymes | Nature Reviews Microbiology
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy | Cancer Gene Therapy
What rheumatologists need to know about CRISPR/Cas9 | Nature Reviews Rheumatology
The kill-switch for CRISPR that could make gene-editing safer
The chemistry of Cas9 and its CRISPR colleagues | Nature Reviews Chemistry
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy | Nature Nanotechnology
Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants | ACS Agricultural Science & Technology
Advances in CRISPR therapeutics | Nature Reviews Nephrology
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology
